Editorial - Post-marketing surveillance – Monitoring, technovigilance and pharmacovigilance

Vigil Sanit Debate, Rio de Janeiro, 2026, v.14: e02602| Published on: 2026-02-04

Authors

  • Flávia Tavares Silva Elias Author
  • Margarete Martins de Oliveira Author
  • Maria Glória Vicente Author
  • Stela Candioto Melchior Author
  • Viviane Cássia Pereira Author

DOI:

https://doi.org/10.22239/2317-269X.02602

Keywords:

Vigilância pós-comercialização, Monitoramento, Tecnovigilância, Farmacovigilância

Abstract

This section of the Visa in Debate Journal will present evidence to support post-marketing surveillance of regulated technologies, such as medicines, food, medical devices (equipment, materials for use in health and in vitro diagnostics), results of strategic studies produced in cooperation between the Oswaldo Cruz Foundation Brasília (Fiocruz Brasília) and the National Health Surveillance Agency (Anvisa). This cooperation aims to produce evidence that can support the regulatory decision-making process and, as a teaching and research institution, Fiocruz Brasília has an interest in disseminating the results from the studies.

________________________________________________________________
1 PROJETO GEREB-005-FIO-21 “Support for actions for the development of regulation and health surveillance".

Downloads

Download data is not yet available.

Published

2026-02-04

How to Cite

Editorial - Post-marketing surveillance – Monitoring, technovigilance and pharmacovigilance: Vigil Sanit Debate, Rio de Janeiro, 2026, v.14: e02602| Published on: 2026-02-04. (2026). Health Surveillance under Debate: Society, Science & Technology , 1-2. https://doi.org/10.22239/2317-269X.02602